Jaguar Uranium Corp. (NYSEAMERICAN:JAGU – Get Free Report) was the target of a significant decline in short interest in August. As of August 14th, there was short interest totaling 92,859 shares, a decline of 43.5% from the July 30th total of 164,325 shares. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 64,491 shares, the short-interest ratio is currently 1.4 days.
Analysts Set New Price Targets
JAGU has been the topic of a number of research reports. Roth Capital started coverage on shares of Jaguar Uranium in a research note on Tuesday, July 7th. They issued a “buy” rating and a $3.20 price target on the stock. Zacks Research raised Jaguar Uranium to a “hold” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $3.20.
Get Our Latest Analysis on Jaguar Uranium
Jaguar Uranium Price Performance
Jaguar Uranium (NYSEAMERICAN:JAGU – Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.04) EPS for the quarter. As a group, analysts anticipate that Jaguar Uranium will post -1.28 EPS for the current year.
Jaguar Uranium Company Profile
Jaguar Uranium, traded on the NYSE American under the ticker JAGU, is a publicly listed company engaged in the exploration and development of uranium resources. The company’s primary focus is identifying, acquiring and advancing uranium-bearing properties with the objective of delineating mineral resources and progressing projects toward potential development.
Jaguar Uranium’s activities typically include geological surveying, drilling programs, resource modeling and the permitting processes required for exploration and eventual mine development.
See Also
- Five stocks we like better than Jaguar Uranium
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Jaguar Uranium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Uranium and related companies with MarketBeat.com's FREE daily email newsletter.
